title: Clozapine use presenting with pseudopheochromocytoma in a schizophrenic patient: a case report.
abstract: Introduction. There have been six previous cases that reported pseudopheochromocytoma in patients taking clozapine. Our case showed the direct link of clozapine to serum levels of certain markers. Case. This is a case of a 49-year-old obese Caucasian female who was referred to endocrinology for investigation of Cushing's syndrome, based on raised blood pressure and Cushingoid facies. The patient had underlying schizophrenia and was stable on clozapine. Her blood pressure was 150/99 mmHg on bendroflumethiazide and candesartan. We measured her 24-hour urinary-free cortisol, which was normal but 24-hour urinary-free noradrenaline was elevated at 835 nmol (76-561) with normal adrenaline 36 nmol (7-82) and dopamine 2679 nmol (366-2879), as the patient had history of palpitations and sweating. Two sets of 24-hour urinary-free cortisol measurements were normal and serum cortisol suppressed to <50 nmol/l after a 1 mg overnight dexamethasone. Two further 24-hour urinary-free catecholamines showed a raised level of noradrenaline. MRI demonstrated normal adrenals and MIBG scan did not show any abnormal uptake at adrenal glands. Conclusion. Pseudopheochromocytoma has been reported in patients taking clozapine. A number of different mechanisms for raised plasma noradrenaline levels with clozapine have been postulated. The above case highlights an unusual but known side effect of clozapine.
authors: University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK.
authors: Jaskanwal
authors: J
authors: Sara
authors: Matt
authors: M
authors: Jenkins
authors: Tanveer
authors: T
authors: Chohan
authors: Karan
authors: K
authors: Jolly
authors: Lisa
authors: L
authors: Shepherd
authors: Nirav Y
authors: NY
authors: Gandhi
authors: Jayadave
authors: J
authors: Shakher
references: Neuropsychopharmacology. 1994 Feb;10(1):1-7
references: 8179790
references: Am J Psychiatry. 1994 Jan;151(1):148
references: 8117356
references: Psychiatry Res. 1993 Feb;46(2):151-63
references: 8483974
references: Clin Neuropharmacol. 1998 Mar-Apr;21(2):139-40
references: 9579304
references: Arch Intern Med. 2000 Sep 11;160(16):2521-4
references: 10979065
references: BMJ. 2001 May 19;322(7296):1213
references: 11358774
references: Ir J Psychol Med. 2003 Dec;20(4):132-134
references: 30308722
references: Neuropsychopharmacology. 1999 Jan;20(1):29-34
references: 9885782
references: J Clin Psychiatry. 1994 Sep;55 Suppl B:122-5
references: 7961555
references: Aust N Z J Psychiatry. 1997 Dec;31(6):889-91
references: 9483266